La maladie de Parkinson au Canada (serveur d'exploration) - Exploration (Accueil)

Index « Mesh.i » - entrée « Cholinergic Antagonists »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
Choline-Phosphate Cytidylyltransferase < Cholinergic Antagonists < Cholinergic Fibers  Facettes :

List of bibliographic references indexed by Cholinergic Antagonists

Number of relevant bibliographic references: 9.
Ident.Authors (with country if any)Title
000435 (2016) James A. G. Crispo [Canada, États-Unis] ; Allison W. Willis [États-Unis] ; Dylan P. Thibault [États-Unis] ; Yannick Fortin [Canada] ; Harlen D. Hays [États-Unis] ; Douglas S. Mcnair [États-Unis] ; Lise M. Bjerre [Canada] ; Dafna E. Kohen [Canada] ; Santiago Perez-Lloret [Argentine] ; Donald R. Mattison [Canada] ; Daniel Krewski [Canada]Associations between Anticholinergic Burden and Adverse Health Outcomes in Parkinson Disease
000483 (2015) James A. G. Crispo [États-Unis] ; Yannick Fortin ; Dylan P. Thibault [États-Unis] ; Matthew Emons [États-Unis] ; Lise M. Bjerre ; Dafna E. Kohen ; Santiago Perez-Lloret [Argentine] ; Donald Mattison ; Allison W. Willis [États-Unis] ; Daniel KrewskiTrends in inpatient antiparkinson drug use in the USA, 2001–2012
002671 (2007) Teri R. Thomsen [Canada] ; Wendy R. Galpem [Canada] ; Abena Asante [Canada] ; Tamara Arenovich [Canada] ; Susan H. Fox [Canada]Ipratropium Bromide Spray as Treatment for Sialorrhea in Parkinson's Disease
002724 (2006) Alex Rajput [Canada] ; Ali H. RajputParkinson's disease management strategies.
002F65 (2002) Oksana Suchowersky [Canada]Parkinson's disease: medical treatment of moderate to advanced disease.
003118 (2001) S B Patten [Canada] ; J V Williams ; R. Petcu ; R. OldfieldDelirium in psychiatric inpatients: a case-control study.
003841 (1999) M. A. Bedard [Canada] ; B. Pillon [France] ; B. Dubois [France] ; N. Duchesne [Canada] ; H. Masson [Canada] ; Yves Agid [France]Acute and long-term administration of anticholinergics in Parkinson's disease : Specific effects on the subcortico-frontal syndrome
003868 (1998) P. Seeman [Canada] ; T. TallericoAntipsychotic drugs which elicit little or no parkinsonism bind more loosely than dopamine to brain D2 receptors, yet occupy high levels of these receptors.
004125 (1994) D B Calne [Canada]Early idiopathic parkinsonism: initiation and optimization of treatment.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Canada/explor/ParkinsonCanadaV1/Data/Main/Exploration
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i -k "Cholinergic Antagonists" 
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/Mesh.i  \
                -Sk "Cholinergic Antagonists" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Canada
   |area=    ParkinsonCanadaV1
   |flux=    Main
   |étape=   Exploration
   |type=    indexItem
   |index=    Mesh.i
   |clé=    Cholinergic Antagonists
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Thu May 4 22:20:19 2017. Site generation: Fri Dec 23 23:17:26 2022